The Different Association between Metformin and Sulfonylurea Derivatives and the Risk of Cancer May be Confounded by Body Mass Index
Journal Title: Journal of Diabetes and Obesity - Year 2016, Vol 3, Issue 2
Abstract
Aim: Several studies in large databases suggest that in comparison to glucose-lowering sulfonylurea derivatives, metformin is associated with a reduced risk of cancer in patients with diabetes. As many databases miss relevant confounder data, our objective was to investigate whether the determinants age, body mass index (BMI), alcohol consumption, and renal function were associated with dispensing of either metformin or sulfonylurea derivatives as first drug therapy for type 2 diabetes mellitus while taking into account calendar time. Methods: We identified 639 incident metformin users and 934 incident sulfonylurea derivatives users in the Rotterdam Study, a prospective population-based cohort study. Associations were studied using logistic regression analyses. Results: After adjustment for all other determinants, starters with metformin had a statistically significantly higher BMI than starters with sulfonylurea derivatives (OR 1.19, 95% CI 1.04 – 1.37 for starters < July 1st 2000; OR 1.23, 95% CI 1.04 – 1.45 for starters ≥ July 1st 2000). Age, renal function, and alcohol consumption were not statistically significantly associated with the probability of dispensing metformin versus sulfonylurea derivative therapy as first drug therapy for type 2 diabetes mellitus. Conclusion: BMI is associated with a higher probability of dispensing of metformin as first drug therapy for type 2 diabetes mellitus in comparison to sulfonylurea derivatives. BMI is associated with the risk of cancer as well as the risk of type 2 diabetes mellitus. Therefore, in studies analyzing the association between the use of metformin or sulfonylurea derivatives and the risk of cancer, BMI should be considered as an essential co-variable.
Authors and Affiliations
Rikje Ruiter
A Calorie is Still a Calorie, According to Rigorous New Evidence
Chronic degenerative “diseases of civilization” are the top challenges of all health systems globally. Among them, obesity is the most pernicious because it a) has survived several meritorious lifestyle initiatives undet...
Effect of Chromium(III) -Amino acid (1:3)Complexes on High Sucrose Induced Insulin Resistance, Lipid Abnormalities - Oxidative Stress in Male Sprague Dawley Rats
This study was carried out to assess the anti-hyperglycaemic effects if any of novel synthetic binary chromium (III)-amino acid complexes in a high sucrose (HS) induced insulin resistance (IR) and or impaired glucose tol...
Potent Anti-Adipogenic Effect of Green Tea and Green Tea Extracts in Chicken
This study was conducted to examine the effect of green tea on body, adipose tissue, and liver weights and adipose tissue weight to body weight ratio and the adipogenic differentiation and expression of adipogenic transc...
Determinants of Misperception of Weight Status Among a Community of Adults in the Region of Sousse, Tunisia
Aim: To determine the prevalence of misperception of body weight status among Tunisian adults in the region of Sousse and examine its associated factors. Materials and Methods: The studied population was randomly selecte...
Risk of Type 2 Diabetes among US - Foreign Born Non-Hispanic Asians: Evidence from NHANES 2011-12
Aims/Introduction: The purpose of this study was to compare risks for metabolic dysfunction and type 2diabetes among Non-Hispanic Asian and Non-Hispanic white adults using new nationally representative data in the U.S. W...